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The transduction pathways that branch out of fibroblast growth factor signaling are essential for the induction of the mesoderm and the
specification of the vertebrate body plan. One of these pathways is thought to control remodeling of the actin cytoskeleton through the Ral binding
protein (RLIP also known as RalBP1), an effector of the small G protein Ral. RLIP contains a region of homology with the GTPase-activating
protein (GAP) domain involved in the regulation of GTPases of the Rho family. We demonstrate here that the GAP domain of RLIP is responsible
for the stability of the actin cytoskeleton in Xenopus laevis embryos. We also demonstrate that the complete N-terminal domain of RLIP
containing the μ2 binding domain (μ2BD) and the GAP domain induces disruption of the actin cytoskeleton when targeted to the plasma
membrane. Neither domain, however, has any effect on the actin cytoskeleton when individually targeted to the plasma membrane. We also
determined that Cdc42-GDP, but neither Rac-GDP nor Rho-GDP, rescues the effect of expression of the membrane-localized Xenopus RLIP on
the actin cytoskeleton. We show that the GAP domain of RLIP interacts in vivo with Cdc42-GTP and Cdc42-GDP. Finally, a single mutation
(K244A) in the GAP sequence prevented embryos from gastrulating. These results demonstrate that to participate in the control of the actin
cytoskeleton, RLIP needs its complete N-terminal region coding for the μ2BD and the GAP domain. We suggest that RLIP, by coordinating two
complementary mechanisms, the endocytosis of clathrin-coated pits and the remodeling of cortical actin, participates in the gastrulation process.
© 2007 Elsevier Inc. All rights reserved.Keywords: RLIP; GAP; Cdc42; Actin cytoskeleton; Xenopus; Gastrulation; RalIntroduction
Gastrulation, a primary event of morphogenesis, results from
the coordination of cell differentiation and cell movement.
Various complex processes such as changes in cell morphology
and cell-cell and cell-extracellular matrix adhesion lead to cell
movement. Each process is the result of multiple intra-cellular
events such as endocytosis, remodeling of the actin cytoskele-
ton, gene transcription, etc., which are all controlled by a
network of protein interactions activated by growth factor⁎ Corresponding author. Fax: +33 1.44 27 52 65.
E-mail address: moreauja@ijm.jussieu.fr (J. Moreau).
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doi:10.1016/j.ydbio.2007.09.027signaling. Thus, fibroblast growth factors (FGFs), acting via
branched pathways, participate in induction of the mesoderm
and in cell movement (Amaya et al., 1991; Ciruna and Rossant,
2001). Whereas the involvement of the FGF pathway in
mesodermal gene expression is relatively well documented, its
involvement in cell movement during gastrulation remains
poorly understood. FGF is, however, known to regulate
different cellular events essential for gastrulation such as cell
shaping and migration (Burdine et al., 1997; Ribeiro et al.,
2002; Schumacher et al., 2004; Yang et al., 2002). Studies in
Xenopus have shown that FGF activates a signaling cascade
that controls mesodermal gene expression through activation of
the small GTP-binding protein Ras (Whitman and Melton,
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lamellipodia formation at the gastrula stage (Wacker et al.,
1998). It has also been shown that the FGF signal directly
affects morphogenetic cell movements during gastrulation
(Ciruna and Rossant, 2001; Yang et al., 2002) and that through
the Sprouty protein, FGF signaling prevents convergent
extension movements, independently of the Ras/MAPK path-
way (Nutt et al., 2001). Thus, FGF appears to be required for the
coordination of cellular behavior during gastrulation. The
coordination of different targets and cell functions by FGF
signaling has also been described in the canonical pathway
involving Ras. Furthermore, it is now clearly accepted that Ras
coordinates many cell functions through its interaction with
various effectors such as the serine-threonine kinase Raf, the
phosphatidylinositol 3-kinase (PI3K), and the Ral GDP
dissociation stimulator RalGDS (for a review, see Vojtek and
Der, 1998). When Ras mutants containing different point
mutations in the Ras effector domain were used, they could
interact selectively with each of the three downstream effectors
characterized; the Raf, the p110 catalytic subunit of PI3K and
the Ral guanine nucleotide exchange factors (RalGEFs) (White
et al., 1995). In contrast to the Raf and the PI3K effectors, the
RalGDS effector does not have its own kinase activity, but
induces the formation of the GTP-bound state of the GTPase
members of the Ral-family. Ral belongs to the Ras superfamily
(Wolthuis and Bos, 1999).
The Ral-GTPases and Ras are important actors in various
aspects of cell behavior such as cell migration (Gildea et al.,
2002), transformation (Urano et al., 1996; Yu and Feig, 2002),
growth and differentiation (Gille and Downward, 1999;
Verheijen et al., 1999) and have been shown to be involved
in metastasis (Ward et al., 2001; Tchevkina et al., 2005). The
overexpression of the mRNA that codes for the activated form
of Ral (Ral-GTP) induces a local depigmentation in the animal
hemisphere of the Xenopus embryo and is correlated with the
disruption of the cortical actin cytoskeleton. These observa-
tions allowed us to demonstrate that the actin network is one
of the targets of the Ras/Ral pathway during early develop-
ment of Xenopus embryos (Moreau et al., 1999). While it is
now well established that Ras activates canonical pathways by
Raf and the PI3Ks, the exploration of the RalGEF pathway is
just beginning (Feig, 2003). During early amphibian develop-
ment, the FGF-inducing signal is mediated by Ras and is
induced through activation of the MAPK cascade (MacNicol
et al., 1993) and PI3K (Carballada et al., 2001), two pathways
that control the expression of many mesodermal genes such as
Xbra expressed in the marginal zone. FGF/Ras has thus been
shown to play a role in the patterning of the marginal zone
(Kumano and Smith, 2000), and through activation of Xbra
expression maintains cell migration and convergent extension
as mutually exclusive behaviors (Conlon et al., 1996; Kwan
and Kirschner, 2003). Nevertheless, although the expression of
activated MAPK has been observed during gastrulation in
mesodermal cells prior to their involution around the
blastopore lip (Curran and Grainger, 2000), it has never been
detected when mesendodermal cells migrate on the blastocoele
roof. Consequently, even if the FGF signal plays a major rolein cell migration, this could be independent of the MAPK
pathway.
We have focused our attention on the Ras/RalGDS pathway
during early development of Xenopus embryos. We showed that
the final target of this transduction pathway is the dynamic
cortical actin network, independently from the activation of new
genes (Lebreton et al., 2004), and that FGF activates the Ral
pathway in the marginal zone during gastrulation (Lebreton et
al., 2003). The expression in the blastula marginal zone of a
dominant-negative form of Ral (RalS28N) or the expression of
the Ral binding domain of RLIP, its effector, inhibits this
branched pathway, inducing gastrulation defects (i.e. spina
bifida, shortening of the anterior–posterior axis, reduction or
lack of anterior embryonic structures). Ral, as do many small G
proteins, behaves like a molecular switch, alternating between
its active and inactive forms to interact with its partners: when
Ral is in its activated form (Ral-GTP), it interacts with an
effector. In Xenopus embryos we have identified RLIP
(Lebreton et al., 2004) as a partner of Ral.
RLIP, the effector of Ral (Jullien-Flores et al., 1995; Cantor
et al., 1995; Ikeda et al., 1998; Lebreton et al., 2004), interacts
with at least three other proteins, the μ2 subunit of the clathrin
adaptor complex AP-2 (Jullien-Flores et al., 2000), POB1/Reps
(Morikana et al., 1999) and the Activin type II receptors
(ActRIIs) (Matsuzaki et al., 2002), and possesses a sequence
that is similar to the primary sequences of protein families that
share a 170–200 amino acid region of homology designated
RhoGAP. The GAP domain of RLIP activates the GTPase
activity of Cdc42 and, to a lesser extent, that of Rac1 (Park and
Weinberg, 1995; Jullien-Flores et al., 1995). Using a mutagen-
esis approach, we demonstrate that the central GAP domain of
RLIP is involved in controlling the stability of the actin
cytoskeleton network via Cdc42. In addition, we demonstrate
that, in vivo, the μ2 interacting domain present in the N-terminal
region of RLIP is necessary for the action of the GAP domain
on the actin cytoskeleton. We also show that interaction
between Cdc42 and the GAP domain of RLIP is required for
gastrulation movements. Thus, during gastrulation, FGF signal
transduction controls involution of dorsal mesodermal cells via
the Ral/RLIP pathway.Materials and methods
Microinjections
They were performed as described (Lebreton et al., 2004). For over-
expression studies, either 4.6 or 9.2 nl of mRNA at the appropriate concentration
was injected near the surface of the animal hemisphere of two-cell stage
embryos or in the marginal zone of four-cell stage embryos with a Nanoject
microinjector (Drummond Sci.).
Construction of deletion mutants and site-directed mutants
To generate the deletion mutants of XRLIP, XRLIP cDNAs in the pRN3
vector, the sequences were amplified by PCR with a 5′ primer containing the
EcoRI site in phase with either the tag Myc sequence or the XRLIP sequence
corresponding to the 5′ limit of the domain to be cloned. The 3′ primer contained
a hybridization sequence corresponding to the XRLIP domain to be cloned with
the CAAX sequence, a termination codon and a NotI site. Its general design
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GACTCGCCGGCGATTGAGC 5′ (termination codon: double underline, and
Not site: single underline). The XRLIP mutants in the GAP sequence were
generated by oligonucleotide-directed mutagenesis of XRLIP in the pRN3
vector by the PCR-based second extension amplification method with the Quick
Change site-directed mutagenesis kit as recommended (Stratagene) and primers
containing the desired mutations. The products were amplified from the cDNA
coding for XRLIP with primers sandwiching the junction site and the 5′ or 3′
end of the mutated coding sequences containing a 5′ EcoRI site and an internal
SacI site. The resulting chimeric inserts were sequence-proofed by Genome
Express.
In vitro transcription of RNA for injection
cDNAs were cleaved after the poly dT sequence with Asp718, and RNA
transcripts were produced using T3 polymerase. Capped mRNAs were obtained
with the mMessage Machine System (Ambion) according to the manufacturer's
instructions.
GAP assay
GAP activity was assessed by prebinding Cdc42 with [γ-32P]GTP. The
GTPase activity was quantified by measuring the decrease in the radiolabeled
protein-GTP complex following incubation with proteins synthesized in vitro.
The XRLIP construct was cloned in the GEX4TI vector fused to GST at its
N-terminus. GST and GST-Cdc42 from transformed Escherichia coli cells were
prepared according to classical methods as described in the Pharmacia manual.
Purified GST fusion proteins were cleaved with thrombin. [γ-32P] GTP-bound
Cdc42, was prepared by incubating 200 nM protein with 25 mM Tris–HCl,
pH 7.5, 5 mM EDTA, 0.2 mM MgCl2, 0.1 mg/ml of BSA, 1 mM DTT, 10 mM
[γ-32P] GTP (30 mCi/mmol (Amersham)) in 50 μl for 15 min at room
temperature. GTP hydrolysis was initiated in the presence of 400–800 nM of
protein in 20 mM MgCl2 and 200 μM GTP. After 15 min, hydrolysis was
stopped with buffer containing 50 mM Tris–HCl pH 8.0, 35 mMMgCl2, 1 mM
DTT and 150 mM NaCl, filtered on BA 85 nitrocellulose filters and the
radioactivity retained on the filter was measured.
Immunostaining of embryos and confocal microscopy analyses
Xenopus embryos at the appropriate stage of development were either
incubated in permeabilization buffer (80 mM HEPES pH 6.8, 1 mM MgCl2,
100 mM EDTA, 30% glycerol and 0.1% Triton X-100) for 15 min at room
temperature before being fixed overnight in 1× PBS and 1.4% formaldehyde, or
their vitellin membrane was manually removed. For either procedure, the
samples were incubated with 9E10, anti-myc antibody was diluted 1:100 in 1×
PBS, 1% BSA and 0.1% Triton X-100. Confocal microscopy observations were
performed as described (Moreau et al., 1999) with a Leica SB2 AOBS confocal
imaging system (Leica Instruments, Heidelberg, Germany).
Western blotting
Embryos were harvested at stages 6–7 and disrupted in 40 μl of lysis buffer
(50 mM Tris–HCl pH 7.5, 100 mM NaCl, 10 mMMgCl2, 1% Triton X-100 and
1 mM PMSF) per embryo by pipetting several times with a yellow tip (Gilson)
and treated twice with the same volume of Freon (Merck) to remove the yolk
(Gusse et al., 1989). The crude protein extracts were mixed with Laemmli buffer,
subjected to SDS–PAGE and transferred to PVDF membranes (Hybond-P,
Amersham) that were probed overnight with the appropriate antibodies (Santa
Cruz Lab.) and peroxidase-conjugated secondary antibodies (Sigma). Signals
were detected by chemiluminescence (ECL, Amersham).
Synthesis and purification of the GST-fusion proteins
cDNAs coding for XRLIP, Rac-GTP and Cdc42-GTP were fused to GST in
the pGEX-4T-1 vector (Pharmacia) and cloned. Protein synthesis in E. coli was
induced by 1 mM IPTG (Euromedex). Clones containing GST-RalAG23V were
subsequently incubated at 37 °C, whereas clones containing GST-XRLIP,XRLIP, GST-Rac-GTP and GST-Cdc42-GTP were incubated at 30 °C to limit
protein degradation. The cultures were then centrifuged and the bacterial pellets
resuspended in buffer D (50 mM Tris–HCl pH 7.5, 100 mM NaCl, 10 mM
MgCl2 and 1% Triton X-100). Cells were lysed by adding 1 mg/ml lysozyme
(Euromedex), and after 1 h at 4 °C, the samples were sonicated, centrifuged at
4 °C for 45 min at 14,000 rpm to remove cell debris and insoluble material and
the supernatants were immediately used.
Recombinant GST proteins were purified on glutathione Sepharose 4B
(Amersham) at room temperature in buffer D according to standard procedures
(Amersham). The purified products were analyzed by SDS–PAGE, and the
concentration of the purified recombinant GST proteins was estimated by
Coomassie Brilliant blue staining using a BSA standard.
GST pull-down
GST pull-down experiments were carried out with 5 μg of GST-RalA, Rac
or Cdc42. The small G proteins were preloaded with GTP γ-S in Mg++-free
loading buffer (20 mM Tris–HCl pH 7.5, 25 mM NaCl, 10 mM EDTA, 1 mM
DTT, 0.05% BSA and 1 mM GTP γ-S) for 1 h at 37° prior to use. The reaction
was stopped by adding 20 mM MgCl2. Using this method, the yield of GTP
loading was about 30%. Reticulocyte extracts (20 μl) were pre-incubated with
5 μg of GST in lysis buffer for 1 h at room temperature and centrifuged. The
supernatants were then incubated with the corresponding GST-fusion protein for
2–3 h at room temperature and centrifuged. All pellets were washed 3 times with
ice-cold buffer D and re-suspended in Laemmli buffer prior to Western blot
analysis.
Co-immunoprecipitation
Embryos were injected with mRNA coding for the appropriate Myc-tagged
cDNA. At the 2000 cell stage, proteins were extracted by lysis of 15 to 20
embryos in 800 ml of buffer A− (50 mM Tris–HCl pH 7.5, 100 mM NaCl and
2 mM PMSF). After 15 min on ice, the extracts were centrifuged at 13,000 rpm
for 30 min. The supernatants were incubated with slow shaking at 4° in the
presence of 3 μl of anti-myc-agarose monoclonal antibody (c-Myc (9E10), Santa
Cruz) and centrifuged at 13,000 rpm for 6 min. The supernatant was discarded
and 32 μl of Laemmli buffer was added to the pellet. The precipitated proteins
were separated by SDS–PAGE and transferred onto a PVDF membrane.
Western blotting was performed as above.
Results
The N-terminal region of XRLIP is involved in disruption of
cortical F-actin
Previous experiments have shown that Ras recruits and
activates the RalGDS protein family at the plasma membrane
(Wolthuis and Bos, 1999). Then the guanine–nucleotide
exchange factor activity of RalGDS activates Ral, which in
turn recruits the RLIP protein to the membrane. So, to mimic the
active location of RLIP independently from activation of Ras/
Ral pathway, we artificially targeted RLIP to the plasma
membrane by adding a CAAX amino acid sequence (CAAX
assay). Previously, we observed that in this condition RLIP
induces the disappearance of pigment (also called bleaching)
(Moreau et al., 1999; Lebreton et al., 2004) on the actin
cytoskeleton. To determine whether a specific sequence of RLIP
is responsible for disruption of the cortical actin cytoskeleton,
RLIP was divided into two parts, both of which were fused to
CAAX to test their action on pigmentation by microinjection
into the animal cap (Fig. 1A). These two segments of RLIP
share the Ral binding domain (RalBD, amino acids 379–477).
The N terminus (XRLIP (1–495)) contains the μ2 binding
Fig. 1. Identification of the RLIP domain that acts on the actin cytoskeleton. Myc-tagged XRLIP deletion mutants were addressed to the plasma membrane by the
CAAX sequence in their C terminus. To compare their relative activities on the actin cytoskeleton, embryos at the two-cell stage were injected into the animal pole of
one blastomere with 300 to 500 pg mRNA. (A) Myc-XRLIP (1–636)-CAAX (full-length) and XRLIP divided in two parts: Myc-XRLIP (1–495)-CAAX (coding for
μ2BD, RhoGAP and RalBD) or the Myc-XRLIP (330–636)-CAAX (coding for RalBD and POB1/Reps) deletion mutants were tested. For XRLIP (1–636)-CAAX
and the mutant containing RhoGAP, and the μ2 and Ral binding domains, depigmentation was observed. (B) Each individual domain of the XRLIP N-terminus:
RhoGAP domain (XRLIP (177–387)-CAAX), the μ2 BD (XRLIP (1–230)-CAAX) or the RhoGAP domain did not induce depigmentation. Left panel: Pictures of the
animal hemisphere of embryos at the large-cell blastula stage. Middle Panel: Localization of XRLIP-CAAX mutants was analyzed with the Myc antibody 9E10 and
secondary antibodies conjugated to FITC. Right panel: Confocal microscopy analysis of the effect of the same mutants on the cortical actin cytoskeleton from the
animal pole. The immunofluorescence images of actin cortical cytoskeleton were obtained by rhodamine–phalloidin. Disruption of cortical actin is observed in
embryos injected with the same mutants that induced bleaching. On the right, schematic presentation of mutants used. The numbers in brackets represent the amino
acids corresponding to the full-length XRLIP that delimits each mutant.
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coding for a RhoGAP domain (amino acids 187–330). The
C-terminus (XRLIP (330–636)) contains the POB1/Reps
interacting domain. mRNA (0.5 ng) of each construct was
injected into the animal hemisphere of two-cell stage embryos
(the animal pole is the pigmented part of the embryo). All the
RLIP constructs contained a myc tag at their N-terminus; thus,
for each mRNA the location of the protein expressed in the
plasma membrane was checked by confocal microscopy using
the anti-myc antibody (Figs. 1A and B middle panel). All
embryos injected with the N-terminal mRNA of RLIP (XRLIP
(1–495)-CAAX) showed clear bleaching of their ectodermal
cells (100%, n=135) (Fig. 1A left panel), as observed when
expression of the full-length XRLIP-CAAX (XRLIP (1–636)-
CAAX) was studied. Conversely, embryos injected with mRNA
coding for the C-terminal region (XRLIP (330–636)-CAAX)
did not display any depigmentation and developed normally up
to the mid blastula transition (MBT) stage. The ectodermal cells
derived from a blastomere injected with XRLIP (330–636)-
CAAX showed a hyperpigmentation phenotype from the end of
the cleavage stage, a phenotype that persisted throughout
development and in which no other developmental abnormal-
ities appeared (in preparation). To confirm that depigmentation
is correlated with disruption of the actin cytoskeleton (as seen
after overexpression of either the Ral-GTP or XRLIP-CAAX),
we analyzed the integrity of the actin network using confocal
microscopy. Whereas embryos injected with XRLIP (330–
636)-CAAX, like the control embryos, possess a cortical
cytoskeleton (Fig. 1A right panel), we observed a dramatic
alteration of the cortical actin cytoskeleton in the blastomeres of
animal caps injected with XRLIP (1–495)-CAAX as in the case
of XRLIP-CAAX expression (Fig. 1A right panel). The
expression of mRNA coding for XRLIP (1–495) without the
CAAX sequence (2 ng per blastomere) did not alter pigmenta-
tion and development of the embryos (not shown). Surprisingly,
when higher quantities of this mRNA were injected, bleaching
of the blastomere was observed, an effect never seen when the
full-length of XRLIP was overexpressed.
To determine precisely whether the μ2 BD or the GAP
domain of the N-terminal region of RLIP is responsible for the
destabilization of the actin cytoskeleton, each domain was fused
to a CAAX sequence (XRLIP (1–230)-CAAX and XRLIP
(177–387)-CAAX)) and their mRNA (0.5 ng/blastomere) was
injected into the blastomeres of the animal hemisphere of
embryos at the two-cell stage. Overexpression of these domains
individually had no effect on either pigmentation of the
blastomere (Fig. 1B left panel) or late embryonic development.
To investigate whether these two domains act on the actin
cytoskeleton, by a possible cooperation when they are associated
in a same protein, XRLIP (1–230)-CAAX and XRLIP (177–
387)-CAAX were coinjected into embryos. As is the case for
individual domains, no abnormal phenotype or disturbance of
the actin cytoskeleton was observed (data not shown).
It was previously demonstrated that the N-terminal domain
of 165 amino acids of the human RLIP is sufficient to interact
with μ2 (Jullien-Flores et al., 2000). Therefore, we tested
whether the targeting to the membrane of the N-terminaldomain of XRLIP deleted of μ2BD and coding only for the
GAP domain (XRLIP (148–387)-CAAX)) affects pigmentation
of the embryos. As observed with the individual domains, no
effect on development was induced by this deletion (Fig. 1B left
panel). Confocal microscopy analyses (Fig. 1B right panel)
confirmed the absence of effect on the actin cytoskeleton. These
observations suggest that, in the N-terminal RLIP domain, the
association of the μ2 BD and the RhoGAP domain of RLIP acts
cooperatively to disassemble the actin cytoskeleton.
Effect of mutations of the GAP domain on the actin
cytoskeleton
The N terminus of XRLIP (1–387) containing the RhoGAP
sequence is the minimum region required to mediate of the
effect of RLIP on the actin network. The GAP domain of the
RhoGAP family contains at least three highly conserved
residues (Arg85, Lys122 and Asn194), which are located in the
putative G protein binding helix pocket and are involved in
binding or catalysis of Rho GTPases (Musacchio et al., 1996;
Barrett et al., 1997). To examine the requirement of RhoGAP
activity, we constructed three XRLIP site-specific mutants:
R208L (208L), K244A (244A) and N317V (317V) correspond-
ing to Arg85, Lys122 and Asn194, respectively, of the consensus
GAP sequence. Since Arg85 is required for the catalytic activity
of GAP (Li et al., 1997), prior to phenotypic analysis we
investigated whether the GAP mutant 208L of XRLIP is as
efficient as the mutated Arg85 described in p190GB (Li et al.,
1997). An activity test (Settleman et al., 1992) was performed in
vitro, in which the level of [γ32P]GTP retained on Cdc42 bound
to GTP was determined when Cdc42 loaded with GTP was
incubated with either wild-type RLIP, XRLIP (1–387), or
XRLIP (1–495). For each construct, the RhoGAP domain had a
similar residual level of bound GTP (35.0±12.0%, 33.7±10.8%
and 26.3±4.6%, respectively) to which is indicative of a similar
activity (Fig. 2A). As reported elsewhere, the level of activity of
the GAP domain in RLIP can be considered low compared to
that of other proteins containing a GAP domain (Jullien-Flores
et al., 1995). Moreover, when tested alone the GAP domain
(177–387) also exhibited a very low level of Cdc42 GTPase
activity since 76.3±11% of [γ32P]GTP remained bound to
Cdc42 after incubation with the GAP domain alone. As
expected, XRLIP (1–387) 208L and XRLIP (1–495) 208L
showed a decrease in GAP activity towards Cdc42-GTP (Fig.
2A) compared with the native form, but the GAP activity
towards Cdc42-GTP was never totally lost. GAP activity,
however, seemed more efficient when it was associated with the
μ2 binding domain alone than when it was associated with the
μ2 and Ral binding domains together.
The biological activity of XRLIP GAP mutants on the actin
cytoskeleton of blastomeres was investigated by examining the
effect of the mutations on embryonic pigmentation. The effects
on the actin cytoskeleton of overexpression of XRLIP (1–387),
containing the RhoGAP domain mutated or not, were compared
when the overexpressed protein was translocated to the plasma
membrane. Each mRNA (1 ng per /blastomere), corresponding
to either mutated or non-mutated XRLIP (1–387)-CAAX, was
Fig. 2. Mutations that affect the activity of the GAP domain reduce the effect of XRLIP-CAAX on the actin cytoskeleton. (A) Effect of the mutation R208L on the GAP
activity of XRLIP. Constructs of wild-type XRLIP (1–636) or XRLIP containing the RhoGAP domain alone (XRLIP (177–387)), associated with the μ2 BD and Ral
binding domains (XRLIP (1–495)), associated with the μ2BD (XRLIP (1–387)) or without the 208L mutation were incubated with (γ-32P) GTP-Cdc42. The products
were separated by filtration and the residual filter-bound radioactivity was determined after incubation. (B) Embryos were injected with mRNAs coding for XRLIP
containing the μ2BD linked to the GAP domain carrying the CAAX sequence (XRLIP (1–387)-CAAX). Three mutations were tested, 208L, 244A and 317V. None of
the embryos injected with a mutated GAP domain presented flaws in their pigmentation. (C) Analysis byWestern blot of protein expression. Each lane was loaded with
protein extracts corresponding to one half embryo and loading was controlled by anti-tubulin and anti-Myc antibodies.
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embryos were examined for any alteration of their pigmentation
from the 32-cell stage onwards. Whereas XRLIP (1–387)-
CAAX induced depigmentation (Fig. 2B) as did XRLIP (1–
495)-CAAX) (Fig. 1A), the same XRLIP construct with the
208L, 244A or 317V mutations did not (Fig. 2B). Using
confocal microscopy, we verified that this absence of depig-
mentation was associated with the absence of damage to the
actin cytoskeleton (data not shown). To confirm that this
inhibition of the effect of the GAP domain on actin cytoskeleton
was due to the presence of the mutation, protein expression was
evaluated by Western blotting and compared to that of
unmutated XRLIP (1–387)-CAAX, which induces blastomere
depigmentation (Fig. 2C). In all cases, the amount of mutated
protein synthesized was equivalent or superior to that of XRLIP
(1–387)-CAAX (Fig. 2C). With the mutants 208L and 317V the
embryos were normal when the amount of mRNA injected was
less than 1.5 ng/ blastomere, and at higher levels they were
depigmented. With the mutant 244A, they were always
depigmented whatever the level of mRNA (data not shown).
Therefore, the 208L, 244A and 317V mutations all alter the
capacity of RLIP to affect both the pigmentation and organiza-
tion of the actin cytoskeleton of the embryos. The two mutants208L and 317V, which do not totally lose their GAP activity, are
less efficient in inhibiting the phenotypic effect induced by RLIP
than the 244A mutant, which appears not to bind to GTPase
proteins (Li et al., 1997). Consequently, in our CAAX assay,
mutations that have been shown to affect GAP activity, lead a
milder bleaching phenotype when the RLIP GAP domain is
targeted to the plasma membrane. These observations provide
clear evidence that the GAP domain of RLIP is involved in the
control of the integrity of the actin network.
Cdc42 is a putative target of XRLIP GAP activity in vivo
The target of the GAP domain of RLIP is Cdc42, and, to a
lesser extent, Rac (Jullien-Flores et al., 1995; Cantor et al.,
1995). To determine which small G protein is the target of RLIP
during early development, the GAP activity of XRLIP was
examined for its possible effect on the activated forms of various
members of the Rho GTPase family. mRNAs coding for Cdc42
12V, Rac 12Vor Rho 12V were injected into embryos alone or
with XRLIP (1–387)-CAAX. Individually, each activated small
G protein mutant induced bleaching of the ectoderm. The
bleaching effect was also observed in the presence of XRLIP (1–
387)-CAAX.We therefore examined whether the action of RLIP
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by coexpression of the dominant-negative forms of Rho
GTPases. mRNAs (1 ng/blastomere) coding for WT Cdc42 or
a dominant-negative form Cdc42 17N, Rho 19N or Rac 17N
were injected alone or with 0.75 ng /blastomere of mRNA
coding for XRLIP (1–387)-CAAX (0.75 ng mRNA/blasto-
mere). When the blastomeres were injected with XRLIP
(1–387)-CAAX alone (Figs. 3B and C) or coinjected with Rho
19N, Rac 17N or Cdc42 WT (Figs. 3H, I, K, L, N and O)
depigmentation was observed in more than 90% of the embryos
(n=40 to 60 for each mRNA) from the cleavage stages (32- or
64-cell) onwards and evolved towards ectoderm lesions during
their development. Because of the lesions these embryos did not
survive beyond the neurula stage. In contrast, coinjection of
XRLIP (1–387)-CAAX mRNA with Cdc42 17N (1 or 0.5 ngFig. 3. Only the dominant-negative form of Cdc42 rescues the depigmentation phenot
with mRNAs coding for Cdc42, Rho or Rac in an inactive form, with Cdc42 WT alon
1–387). Individually, the small G proteins of the Rho family do not induce pigment
inactivated forms or Cdc42 wt induces bleaching of the animal hemisphere (H, I, K a
corresponds to an enlargement of the area delimited by the yellow rectangle.mRNA/blastomere) did not affect pigmentation during the
cleavage stage (Figs. 3E end F) (92%, n=50). Nevertheless,
during gastrulation, these embryos failed to close their
blastopores and did not survive beyond stage 32 as determined
with sibling embryos. Hence, only the dominant-negative form
of Cdc42 rescues the deleterious effects caused by targeting of
the N-terminal region of RLIP to the membrane. This indicates
that the sequestration of Cdc42 GEFs was sufficient to block the
deleterious effects of the GAP domain of RLIP on the integrity of
the actin network. These results are consistent with observations
made in vitro (Jullien-Flores et al., 1995; Park and Weinberg
1995; Cantor et al., 1995) and indicate that the GAP domain of
RLIP requires Cdc42-GTP to induce bleaching of the embryos.
Hence, during early development, RLIP controls the dynamics
of the actin cytoskeleton through the small G protein Cdc42.ype induced by XRLIP-CAAX. The animal hemisphere of embryos was injected
e, or with RLIP-CAAX containing the μ2BD and the GAP domain (amino acids
ation (D, G, J and M), whereas XRLIP-CAAX coinjected with either Rho, Rac
nd L). Only Cdc42 17N rescues the bleaching of embryos (E and F). Right panel
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Since RLIP requires Cdc42 during early development, we
examined whether RLIP targeted to the plasma membrane
could recruit a cytosolic form of Cdc42 such as Cdc42-GTP. To
inhibit normal targeting of Cdc42 12V to the plasma
membrane, the cysteine at position 188, which is part of the
CAAX sequence, was mutated to serine (Cdc42 12V C188S).
No phenotype occurred when at most 0.4 ng/blastomere of
mutated mRNA were injected (n=54) (Fig. 5D). One
blastomere of the animal hemisphere at the two-cell stage
was injected with the amount of XRLIP-CAAX mRNA (0.5 ng/
blastomere) that does not induce depigmentation (Figs. 4B)
alone or together with 0.2 ng/blastomere of Cdc42 12V C188S
mRNA (Fig. 4C). As expected, no effect on the phenotype was
observed (n=45) when XRLIP-CAAX was injected alone. In
contrast, when the same amounts of XRLIP-CAAX mRNA and
Cdc42 12V C188S mRNA were coinjected, as above, there
resulted a clear depigmentation of the animal pole at the 32-cellFig. 4. Synergistic effect of XRLIP-CAAX and Cdc42 12V C188S. (A) The
animal hemisphere of embryos were injected with 200 pg XRLIP-CAAX
mRNA or 50 pg Cdc42 V12 C188S mRNA alone, or coinjected with the same
amounts of mRNAs. Only coinjection induced bleaching of the embryo. At least
40 embryos of two independent experiments were scored for each mRNA
microinjected. (E) Each lane was loaded with protein extracts corresponding to
one half embryo and tested with the appropriate antibodies (anti Myc for the
XRLIP-CAAX constructs and anti-Cdc42).stage (93%, n=56) (Fig. 4C). To ensure that the depigmentation
was not due to an unexpected ratio of translation of the two
proteins, the levels of XRLIP and Cdc42 expressed were
determined by Western blot. All the XRLIP constructs were
fused with the Myc epitope, and their protein products were
detected by an anti-myc antibody and the Cdc42 protein by
anti-Cdc42 antibodies. The results show that the levels of
expression of XRLIP and Cdc42 were equivalent (Fig. 4E).
These results provide evidence that, in embryonic blastomeres,
activated Cdc42 and XRLIP-CAAX have a synergistic effect
on the integrity of the actin cytoskeleton and strongly suggest
that this could result from their direct interaction with each
other.
Cdc42 interacts in vivo with XRLIP
To examine whether a possible direct molecular interaction
between the proteins Cdc42 and XRLIP occurs in vitro, the
lysates of embryos expressing Myc–XRLIP were incubated
with GST-RalA 23V, GST-Rac 12V or GST-Cdc42 12V, each
one charged with [γ-32P]GTP. GST-RalA 23V and GST-Cdc42
12V precipitated RLIP but not GST or GST-Rac 12V (Fig. 5A),
showing RLIP and GST-Cdc42 12V interact in vitro with
apparently high affinity. To determine whether these interac-
tions occur in vivo, the embryos were injected with mRNAs
corresponding to the full-length Myc-XRLIP (Fig. 5B) or
mRNAs composed of different XRLIP constructs containing or
not the RhoGAP domain as did the XRLIP (330–636) (Fig.
5C). Anti-myc agarose beads served to analyze the amount of
endogenous Cdc42 retained with Myc-XRLIP. When Myc-
XRLIP or Myc-XRLIP-CAAX were expressed in the embryo,
endogenous Cdc42 protein was retained on the beads (Fig. 5B)
as well as when the mutants were expressed (Fig. 5C). Except
for XRLIP (330–636), the deletion mutants that contained the
RhoGAP domain all bound to endogenous Cdc42 (Fig. 5C).
The 208L 317V double mutant exhibited a weaker reproducible
co-immunoprecipitation signal. This confirms the study carried
out on the GAP domain of p190 showing that mutations of
Arg85 or Asn194 are not essential for the binding of Rho (Li et
al., 1997). Even if the amounts of Cdc42 retained on the beads
were not equivalent in the different experiments, the presence of
Cdc42 in the protein fraction retained by the beads is sufficient
on its own to show that Cdc42 can interact with the XRLIPs in
vivo and establishes a direct interaction between Cdc42 and the
GAP domain of XRLIP in embryonic cells.
The rescue and synergistic experiments described here
suggest a link between XRLIP and Cdc42-GTP. The pull
down and GST experiments described above, in Fig. 4 and two-
hybrid experiments (data not shown), confirm that this
interaction is due to the specific affinity of the GAP domain
of XRLIP for Cdc42-GTP and not for Cdc42-GDP or Rac.
We therefore examined whether the interaction with Cdc42
in vivo is specific to the GTP form or whether it can be
extended to the GDP form. Myc-Cdc42 harboring either the
12Vor 17N mutation was expressed, and the embryos analyzed
for their ability to interact with RLIP using co-immunopreci-
pitation. Fig. 5D shows that comparable amounts of XRLIP
Fig. 5. Cdc42 interacts with the GAP domain of XRLIP. (A) In vitro, GST-RalA, Rac and Cdc42 loaded with γ-32P GTP were mixed with or without protein extracts
from 10 embryos, precipitated with glutathione-Sepharose beads, washed, eluted in SDS and separated by SDS–PAGE followed by autoradiography. Cdc42 and RalA
interacted with XRLIP, whereas GST or Rac did not present a signal with anti-Myc antibody. (B) Co-immunoprecipitation (Co-IP) of endogenous Cdc42 with Myc-
XRLIP or XRLIP-CAAX. (C) Co-IP of endogenous Cdc42 with different deletion mutants of XRLIP (see Fig. 1 for details of domains tested). (D) Co-IP of
endogenous RLIP with Myc-Cdc42 17N or 12V. Data are representatives of at least three independent experiments.
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complex. Hence, not only Cdc42-GTP but also Cdc42-GDP
interacts with the GAP sequence of XRLIP in vivo.
The N-terminal region of XRLIP is involved in the gastrulation
In previous studies, we showed that RalB is necessary for
gastrulation (Moreau et al., 1999; Lebreton et al., 2003), and
here we show that RLIP, its effector, has to target the dynamic
cytoskeleton actin. We therefore sought to determine whether
the N-terminal domain of RLIP implied in the dynamic
cytoskeleton actin is also involved in gastrulation. To this end,
we were able to express in the marginal zone of embryos the full-
length XRLIP (1–636), the C-terminal (379–636) part contain-
ing the RalBD and Reps BD or the C-terminal (468–636) part
containing only the RepsBD, each one in the absence of the
CAAX sequence. Thus, targeting of XRLIP (1–636) and XRLIP
(379–636) to the plasma membrane is dependent on the
activation of Ral, whereas XRLIP (468–636) cannot interact
with Ral.
When 800 pg of XRLIP (379–636) mRNA were injected
into the equatorial zone of each blastomere, gastrulation of the
embryos was arrested and no blastopore closure (100%, n=46)(Fig. 6Be) occurred. Cross-sections of these embryos (Fig. 6Ab)
clearly show the lack of archenteron and internalization of
mesodermal cells. In contrast, overexpression with 2 ng/
blastomere of wild-type RLIP mRNA (corresponding to
XRLIP (1–636)) had no effect on development (Figs. 6Aa
and d). As well as defects in blastopore closure, the blastocoele
roofs of some embryos injected with XRLIP (379–636) mRNA
showed a thick layer of cells. To confirm that this gastrulation
defect was due to competition for Ral between endogenous
RLIP and XRLIP (379–636), the part of RLIP coding for the
POB1/Reps interaction domain without the Ral binding domain
(XRLIP (468–636)) was injected. No effect on blastopore
closure was observed (Figs. 6Ac and f). When wild-type XRLIP
was coinjected with XRLIP (379–636), less than 50% (n=54)
of the embryos were completely blocked at the gastrulation
stage. The rescue experiment was restricted by the size of the
XRLIP mRNA (1.9 Kb), which limits any increase in the ratio
between wild-type and mutant mRNA that must be coinjected to
achieve a complete rescue. Partial rescue, however, indicates
that XRLIP can compete for the XRLIP (379–636) mutant,
whereas coinjection of wild-type XRLIP mRNA, with an
equimolar amount of β-Gal mRNA does not interfere with the
phenotypic effect (Lebreton et al., 2004). Together, these data
Fig. 6. Effect of RLIP deletion mutants and GAP domain mutant induces severe on gastrulation. (A) Embryos at four-cell stage were injected into the marginal zone.
(d, e and f) Vegetal view of embryos at 12.5 stage. (a, b and c) cross-section of embryos corresponding to the same stage of development. White arrows indicate the
archenteron and the arrowheads the site of blastopore formation. (B) Schematic representation of the XRLIP deletion mutants without the CAAX sequence, used in
embryos shown in the upper pictures. Letters in bracket corresponds to the mutants used in the pictures. (C) Embryos injected with mRNAs coding for WT XRLIP or
mutants into the four blastomeres in the marginal zone. (D) Quantification of embryos with an abnormal phenotype at the 35–36 stage. Embryos were injected with
0,8 ng mRNAs in the marginal zone at the four-cell stage in the two dorsal blastomeres (grey) and in all four blastomeres (white). (E) Phenotypes of Xenopus embryos
injected in the dorsal marginal zone with RNA encoding XRLIP 244A. (F) Embryos coinjected with XRLIP or XRLIP 244A and GFP mRNAs into the two dorsal
blastomeres at the four-cell stage. The cells that express XRLIP are identified by GFP fluorescence during the different stages of early development. The embryos
injected with RLIP 244A show fluorescence in a more posterior location than embryos injected with XRLIP.
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interaction of the endogenous RLIP with Ral and interferes with
the gastrulation process.
These results clearly demonstrate that the local bleaching
phenotype and actin disruption are caused exclusively by the μ2BD and the GAP sequence of the N-terminal part of RLIP, when
they are targeted together to the plasma membrane. Moreover,
they suggest that the N-terminal domain of RLIP is also
necessary for a complete gastrulation; since the expression of
RLIP without this domain, when it competes with the
Fig. 7. Model for recruiting of protein complex by RLIP during gastrulation.
Activation of FGF sequentially recruits proteins that activate Ras. Activated Ras
interacts with RalGDS that in turn activates Ral. RLIP then interacts with Ral
and is used as a platform allowing interaction with many proteins such as Cdc42,
through its GAP domain, and μ2 a subunit of the adaptor protein complex AP-2.
Together Cdc42 and μ2 are involved in endocytosis and locally control the
dynamics of cortical cytoskeleton actin. (?) Corresponds to the interaction with
unidentified proteins.
341L. Boissel et al. / Developmental Biology 312 (2007) 331–343endogenous RLIP for interaction with Ral, leads to the arrest of
gastrulation.
Expression of GAP mutants results in altered gastrulation and
cell movements
Once targeted to the plasma membrane, the effect of the
N-terminal region of RLIP on the actin network depends on the
integrity of the GAP domain. The same region of RLIP is
essential for gastrulation. To determine whether the effect of the
GAP domain is also required for gastrulation, the effect on
gastrulation of two GAP activity mutations (208L and 244A)
was tested. These mutations confer different molecular proper-
ties; 208L acts on the GAP activity directly, while 244A has
been shown to be critical for binding to Rho proteins (Li et al.,
1997). mRNAs coding for these XRLIP mutants were injected
(1 ng/blastomere) with GFP mRNA, either radially into the
marginal zone or into the dorsal marginal zone of four-cell
Xenopus embryos. In all embryos injected with either mutant
the onset of blastopore closure was delayed (Fig. 6C), leading to
failure of blastopore closure at the neurula stage. At the tadpole
stage, anterior–posterior structures were greatly reduced and,
for some embryos, the anterior structures were absent. In
embryos that exhibited the most severe gastrulation defects, the
anteroposterior axis was not established. Mutant 244A
produced more pronounced effects than mutant 208L (Fig.
6D). The XRLIP 244A mRNA, coinjected with GFP mRNA
into the marginal zone of two dorsal blastomeres at the four-cell
stage, induced a defect in the blastopore lip in the zone where
GFP expression (Fig. 6F) was observed. Later, embryos showed
severe gastrulation defects, such as a shortened trunk or an
absence of axis (Figs. 6E and F). Moreover, the GFP
fluorescence signal shows that the cells expressing XRLIP
244A failed to migrate in the embryos (Fig. 6F) compared to
embryos coinjected with wild-type XRLIP (Fig. 6F). Together,
these data provide additional evidence that the GAP sequence of
RLIP is needed for gastrulation.
Discussion
RLIP is a crucial element in the Ras cascade leading to cell
spreading and migration (Oshiro et al., 2002 210; Goldfinger et
al., 2006). Studies on Xenopus embryos have shown that the
Ras/Ral/RLIP pathway plays an important role in mesendoderm
migration during gastrulation (Lebreton et al., 2004). Here we
extend these observations to examine how RLIP participates in
the control of the dynamics of the actin cytoskeleton and in
gastrulation. To this end, we defined the N-terminal domain of
RLIP involved in cortical actin disruption.
In early embryos, when different combinations of the
XRLIP domains were targeted to the plasma membrane, the
N-terminal sequence (amino acids 1 to 387) containing both the
μ2 BD and the RhoGAP sequence was necessary and sufficient
to act on the cortical actin. In the absence of the first 148 amino
acids, the GAP sequence was unable either to induce the
depigmentation phenotype or to act on the cytoskeleton of the
cortical actin (Figs. 1A and B). However, the XRLIP GAPdomain alone can interact with Cdc42-GTP (Fig. 6C). This
suggests that the GAP sequence of RLIP is not sufficient to
ensure the biological properties of RLIP in vivo but requires
that other parts of RLIP itself interact with an additional protein
(s) to regulate the action of RLIP on the actin cytoskeleton. To
date, μ2 is the only protein known to bind the N-terminal RLIP
sequence (Jullien-Flores et al., 2000) and thus might be a good
candidate to participate in the action of RLIP in vivo. The μ2
BD is a subunit of the AP-2 complex, an important structural
component of the plasma membrane clathrin-coated vesicles.
Reorganization of the actin cytoskeleton is essential for cell
migration, and it has been shown to be involved in the
formation and internalization of clathrin pits (Yarar et al.,
2005). Cdc42 controls the activity of N-WASP and the
recruitment of proteins involved in remodeling of the actin
skeleton (Benesch et al., 2005).
Using an in vitro assay to test GAP activity and by titration
of a specific GEF protein, we and others (Cantor et al., 1995;
Jullien-Flores et al., 1995; Park and Weinberg, 1995) have been
able to show that the GAP sequence of RLIP displays a greater
specificity towards Cdc42 than towards Rac and the other small
G proteins tested. Pull-down GST and co-immunoprecipitation
experiments confirm that Cdc42 is the direct target of RLIP
GAP. Co-immunoprecipitation of endogenous RLIP with
Cdc42 GTP or Cdc42 GDP reveals that Cdc42, whether
activated or not, interacts with the GAP domain. This
observation and the low level of GTPase activity suggest that,
as for IQGAP (Hart et al., 1996), RLIP could be an effector for
Cdc42 and might provide a direct link between the GTPase and
the actin cytoskeleton. Our experiments demonstrating that
XRLIP-CAAX requires Cdc42-GTP to induce bleaching of
embryos and the synergistic effect of Cdc42-GTP on XRLIP-
CAAX support the hypothesis of a direct interaction between
these two proteins to mediate actin rearrangement. The
emerging evidence favors a model (Fig. 7) where Ral recruits
RLIP at the plasma membrane and this can in turn recruit
Cdc42-GTP by its GAP domain. This complex, which is
focused on RLIP, might locally control the cortical actin cyto-
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formation. This mechanism might be controlled by the low
GAP activity of RLIP and thereby depend on the half-life of the
interaction of Cdc42-GTP with Ral/RLIP.
Using mutations of the GAP domain, we can correlate the
activity of this domain with both the actin cytoskeleton and
gastrulation. The 208L mutation that acts on the GAP activity
(Li et al., 1997) affects the closure of the blastopore less
severely than the 244A mutation, which showed a clear delay in
the onset of blastopore closure and at later stages this delay
resulted in anterior–posterior axis failure (Figs. 6C and D).
Therefore, the RLIP GAP sequence may not really be functional
on its own; instead it is possible that Cdc42 is recruited to the
site where it is necessary for its action on the actin cytoskeleton.
Yet as suggested above and by the group of Camonis (Jullien-
Flores et al., 1995), the weak GAP activity of RLIP might
control this action by prolonging the interaction between GAP
and Cdc42. Due to the great number of reports concerning the
control of cortical actin networks in cell migration (for reviews
see Suetsugu and Takenawa (2003) and Ridley (2001), our data
strengthen the hypothesis that RLIP is involved in regulating the
migratory behavior of ingressing mesendodermal cells during
gastrulation.
In addition, our results demonstrate the involvement of
RLIP on gastrulation. The maternal expression of RLIP and its
lengthy half-life are a limitation when morpholino experiments
are performed. However, the fact that a single specific mutation
(244A or 208L), which interferes either with the interaction
between RLIP and Cdc42 or with GAP activity, prevents
blastopore closure, reinforces the possibility that RLIP is
involved in this developmental process. Moreover, expression
of these mutants induced defects in dorsal mesendodermal cell
migration (Fig. 6F) inside the embryo and suggests that, during
early stages of gastrulation, RLIP is required to maintain the
mesodermal migration property. The shortened axis induced by
RLIP mutants (Fig. 6E) also suggests that convergent
extension movements are perhaps disrupted. Thus, during
gastrulation, the FGF signal could participate in morphogenetic
movement through two distinct transduction pathways that act
on two types of cell behavior. In addition, these combined
results are consistent with the proposal that Ras, an element of
the FGF signaling pathway, acts as a spatial-temporal switch
for the activation of mesodermal genes through its interaction
with Raf and later for cell migration through interaction with
the effector RalGDS.
To summarize, although the possibility remains that RLIP
binds GDP- or GTP-loaded GTPases with different affinities
under non-saturating conditions, the results we present here
suggest that RLIP might be important both in regulating Cdc42
via its GAP sequence and in properly localizing different
components within the plasma membrane microdomain of the
cell where it acts on the dynamics of F-actin. The Ral pathway
appears to be involved in EGF receptor endocytosis (Nakashima
et al., 1999; Jullien-Flores et al., 2000). By recruiting different
partners, RLIP might participate in the internalization of an FGF
receptor, which activates the Ral protein in the marginal zone of
migrating cells (Lebreton et al., 2003), but also in theinternalization of integrins for cell migration of mesendodermal
cells. In the cell motility process, the integrins mediate inter-
action with the extracellular matrix and are recycled by
endocytosis from the rear of the cell to its leading edge
(Lawson and Maxfield, 1995). This would mean that RLIP is
directly involved in cell migration when recruited by Ral. The
Ral mutant lacking affinity for RalBP1 (RalBP1 is also
designated RLIP) exhibits a much lower cell motility (Suzuki
et al., 2000). Internalization might be achieved by μ2 BD and
clathrin pit formation and might be facilitated by local
remodeling of the cortical actin cytoskeleton by the GAP
domain (Fig. 7). Further studies are necessary to confirm the
function of RLIP on endocytosis during gastrulation, and
interaction of RLIP with μ2. These data show that the
interaction of RLIP with Cdc42 participates in the remodeling
of the actin cytoskeleton and in mesodermal cell movement
during gastrulation. Yet it remains to be established how RLIP
regulates Cdc42 to control actin cytoskeleton remodeling. It will
also be necessary to specify which of the following mechan-
isms-cell adhesion, cell shaping or cell migration-are controlled
by Ral//RLIP and which type of behavior-mesendoderm
migration or convergent extension-depends on RLIP during
gastrulation.
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